iShares Russell 2000 ETF vs Roivant Sciences Ltd. Common Shares — how do they compare? iShares Russell 2000 ETF trades at $278.93 (market cap $77.70B), while Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B). The key difference: iShares Russell 2000 ETF is far larger — about 3.1× Roivant Sciences Ltd. Common Shares's market cap, and iShares Russell 2000 ETF is more actively traded (35,598,983 versus 6,279,442). Which is the better fit depends on your goals — on Pluang, investors hold iShares Russell 2000 ETF for 83 Days and Roivant Sciences Ltd. Common Shares for 1 Days on average.
| IWM | ROIV | |
|---|---|---|
Market Cap | $77.70B | $24.72B |
Volume | 35,598,983 | 6,279,442 |
52-Week High | $305.06 | $41.81 |
52-Week Low | $229.13 | $16.04 |
Typical Hold Time | 83 Days | 1 Days |
Sector | — | Health |
Enterprise Value | — | $20.99B |
Signals from Pluang's Aura AI — not financial advice
IWM trades at $277.63, showing minimal daily movement with a slight decline of 0.03%. Technical indicators signal a bearish trend with moving averages and ADX pointing downward, while oscillators remain neutral. The ETF faces headwinds from Federal Reserve rate hike concerns and underperformance relative to large-cap indices. Recent institutional selling and negative media coverage highlight ongoing challenges for small-cap exposure.
The outlook remains cautious as small-caps face pressure from tightening financial conditions and energy price volatility. While offering diversification from tech-heavy indices, IWM's inclusion of unprofitable companies and decade-long underperformance versus the S&P 500 present significant hurdles for near-term outperformance.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
The ETF is designed to track the performance of the securities and the stocks in the Russell 2000 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on IWM →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →